Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Obstetrical and Gynecological Survey
Journal
Overview
Identity
Overview
Publication Venue For
All-Cause Mortality in Reproductive-Aged Females by State: An Analysis of the Effects of Abortion Legislation
. 78:106-108.
2023
Treatment for Mild Chronic Hypertension During Pregnancy
. 77:634-636.
2022
Where Are We in Understanding the Natural History of Polycystic Ovary Syndrome? A Systematic Review of Longitudinal Cohort Studies
. 77:535-536.
2022
Association of SARS-CoV-2 Infection with Serious Maternal Morbidity and Mortality from Obstetric Complications
. 77:457-459.
2022
Changing Patterns in Medication Prescription for Gestational Diabetes during a Time of Guideline Change in the USA: A Cross-Sectional Study
. 77:455-457.
2022
Development of a Simplified Patient-Centered Pelvic Floor Surgery Complication Scale
. 77:472-473.
2022
Treatment for Mild Chronic Hypertension During Pregnancy
. 77:460-462.
2022
A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection
. 77:16-18.
2022
Evaluating Meaningful Levels of Financial Toxicity in Gynecologic Cancers
. 76:474-476.
2021
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
. 76:10-13.
2021
When to operate, hesitate and reintegrate: society of gynecologic oncology surgical considerations during the covid-19 pandemic
. 76:88-90.
2021
Low-Dose Aspirin for the Prevention of Preterm Delivery in Nulliparous Women with a Singleton Pregnancy (ASPIRIN): A Randomized, Double-blind, Placebo-Controlled Trial
. 75:325-327.
2020
Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping with Death or Severe Intraventricular Hemorrhage among Preterm Infants
. 75:212-214.
2020
Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery Versus Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial
. 75:25-27.
2020
Effect of Vaginal Mesh Hysteropexy Versus Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial
. 75:23-25.
2020
Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement
. 74:703-704.
2019
The Efficacy and Safety of Tipapkinogen Sovacivec Therapeutic HPV Vaccine in Cervical Intraepithelial Neoplasia Grades 2 and 3: Randomized Controlled Phase II Trial with 2.5 Years of Follow-up
. 74:529-530.
2019
A 12-month clinical durability of effectiveness and safety evaluation of a vaginal bowel control system for the nonsurgical treatment of fecal incontinence
. 74:404-405.
2019
Evidence-based review of vaginal native tissue hysteropexy for uterovaginal prolapse
. 74:429-435.
2019
Effect of immediate vs delayed pushing on rates of spontaneous vaginal delivery among nulliparous women receiving neuraxial analgesia: A randomized clinical trial
. 74:131-133.
2019
Neonatal Outcomes of Elective Early-term Births After Demonstrated Fetal Lung Maturity
. 74:66-67.
2019
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
. 73:689-690.
2018
Surgical outcomes after apical repair for vault compared with uterovaginal prolapse
. 73:347-348.
2018
Association of Pharmacologic Treatment of Urgency Urinary Incontinence with Sleep Quality and Daytime Sleepiness
. 73:273-274.
2018
Effect of Therapeutic Hypothermia Initiated after 6 Hours of Age on Death or Disability among Newborns with Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial
. 73:141-143.
2018
The FL/AC Ratio for Prediction of Shoulder Dystocia in Women with Gestational Diabetes
. 73:129-130.
2018
Lessons Learned from Domestic and International Human Papillomavirus Vaccination Programs: A Review
. 73:94-95.
2018
Contraception after Delivery among Publicly Insured Women in Texas: Use Compared with Preference
. 73:5-6.
2018
Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials
. 73:22-24.
2018
Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence
. 72:709-711.
2017
Comparison of Vaginal Hysterectomy Techniques and Interventions for Benign Indications: A Systematic Review
. 72:533-534.
2017
Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement
. 72:515-517.
2017
Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy
. 72:464-465.
2017
Readmission and Prolapse Recurrence after Abdominal and Vaginal Apical Suspensions in Older Women
. 72:161-163.
2017
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
. 72:71-73.
2017
Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
. 72:11-13.
2017
Antenatal betamethasone for women at risk for late preterm delivery
. 71:453-455.
2016
Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
. 71:344-345.
2016
Delayed Cord Clamping in Preterm Neonates: A Review of Benefits and Risks
. 71:39-42.
2016
Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012
. 71:7-9.
2016
A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis
. 70:735-737.
2015
Sexual Health in America: Improving Patient Care and Public Health
. 70:752-754.
2015
Between-hospital variation in treatment and outcomes in extremely preterm infants
. 70:549-551.
2015
Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease
. 70:489-490.
2015
A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women
. 70:446-448.
2015
Tenofovir-based preexposure prophylaxis for HIV infection among African women
. 70:444-446.
2015
A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: The ACT cluster randomized trial
. 70:379-381.
2015
A vaginal bowel-control system for the treatment of fecal incontinence
. 70:387-388.
2015
Effect of depth and duration of cooling on deaths in the NICU among Neonates with hypoxic ischemic encephalopathy: A randomized clinical trial
. 70:235-238.
2015
Why do pregnant women die? A review of maternal deaths from 1990 to 2010 at the University of Alabama at Birmingham: Editorial comment
. 70:155-157.
2015
Vitamin D deficiency is associated with increased fecal incontinence symptoms
. 70:87-88.
2015
American society of clinical oncology position statement on obesity and cancer
. 70:28-29.
2015
Bowel preparation before vaginal prolapse surgery: A randomized controlled trial
. 69:252-253.
2014
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials
. 69:83-85.
2014
Prenatal whole-genome sequencing: Is the quest to know a fetus's future ethical?
. 69:197-199.
2014
Urinary bacteria in adult women with urgency urinary incontinence
. 69:327-328.
2014
What happens to the posterior compartment and bowel symptoms after sacrocolpopexy?: Evaluation of 5-year outcomes from E-CARE
. 69:734-735.
2014
Activity restriction among women with a short cervix
. 68:727-728.
2013
Implementing genomic medicine in the clinic: The future is here
. 68:621-623.
2013
Urinary incontinence in the 12-month postpartum period
. 68:629-630.
2013
Caffeine and urinary incontinence in US women: Editorial comment
. 68:432-433.
2013
Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures: Editorial comment
. 68:434-435.
2013
Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix: Editorial comment
. 68:425-427.
2013
Measuring outcomes in urogynecological surgery: Perspective is everything
. 68:355-357.
2013
Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence
. 68:102-104.
2013
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome
. 67:707-709.
2012
A midurethral sling to reduce incontinence after vaginal prolapse repair
. 67:629-631.
2012
A randomized trial of urodynamic testing before stress-incontinence surgery
. 67:628-629.
2012
Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation
. 67:215-217.
2012
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial
. 66:427-429.
2011
Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia
. 66:285-287.
2011
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
. 66:143-144.
2011
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet
. 65:769-770.
2010
17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length
. 65:477-478.
2010
Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection
. 65:484-485.
2010
Outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy
. 65:217-218.
2010
A multicenter, randomized trial of treatment for mild gestational diabetes
. 65:69-70.
2010
Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length
. 65:73-74.
2010
Effects of periodontal therapy on rate of preterm delivery: A randomized controlled trial
. 65:6-7.
2010
Vaccine prevention of maternal cytomegalovirus infection
. 64:502-504.
2009
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial
. 64:521-523.
2009
Timing of elective repeat cesarean delivery at term and neonatal outcomes
. 64:293-295.
2009
Weight loss to treat urinary incontinence in overweight and obese women
. 64:317-318.
2009
Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife implications for the "timing hypothesis"
. 64:174-176.
2009
Factors associated with 5-year risk of hip fracture in postmenopausal women
. 63:234-235.
2008
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
. 63:232-233.
2008
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters: Commentary
. 62:245-247.
2007
Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial
. 61:496-497.
2006
Low-Fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized controlled dietary modification trial
. 61:454-456.
2006
Low-fat dietary pattern and risk of cardiovascular disease: The women's health initiative randomized controlled dietary modification trial
. 61:451-453.
2006
Low-fat dietary pattern and risk of colorectal cancer: The women's health initiative randomized controlled dietary modification trial
. 61:456-458.
2006
Calcium plus vitamin D supplementation and the risk of colorectal cancer: Commentary
. 61:389-390.
2006
Calcium plus vitamin D supplementation and the risk of fractures: Commentary
. 61:386-388.
2006
Subclinical hypothyroidism and pregnancy
. 61:415-420.
2006
Effectiveness of treatment strategies of some women with pelvic inflammatory disease
. 61:23-25.
2006
A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia
. 60:96-97.
2005
Bacterial vaginosis and risk of pelvic inflammatory disease
. 60:99-100.
2005
Vulvovaginal symptoms in women with bacterial vaginosis
. 60:26-28.
2005
Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review
. 58:351-358.
2003
A guest editorial: Stump the professor
. 57:785-787.
2002
Impact of Maternal Group B Streptococcal Screening on Pediatric Management in Full-Term Newborns
. 52:168-169..
1997
Necrotizing fasciitis after cesarean delivery
. 89:409-412.
1997
Second-trimester maternal serum ca-125 versus estriol in the multiple-marker screening test for down syndrome
. 89:359-363.
1997
Longitudinal changes in adiposity associated with pregnancy: The cardia study
. 50:4-6.
1995
Open laparoscopy without special instruments or sutures: Comparison with a closed technique
. 49:687-688.
1994
Physicians’ behavior and their interactions with drug companies: A controlled study of physicians who requested additions to a hospital drug formulary
. 49:550-553.
1994
Vaginal delivery from the persistent occiput posterior position: Influence on maternal and neonatal morbidity
. 49:530-532.
1994
A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva
. 48:125-126.
1993
Cross-sectional study examining the relationship between fetal urine production and the amniotic fluid index at 38–43 weeks of gestation
. 48:728-729.
1993
Hypothalamic-pituitary dysfunction after radiation for brain tumors
. 48:428-432.
1993
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status
. 47:544-546.
1992
Predictors of morbidity and mortality in neonates with herpes simplex virus infections
. 46:451-453.
1991
21-Hydroxylase deficiency in female hyperandrogenism: Screening and Diagnosis
. 45:132-133.
1990
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome
. 43:543-545.
1988
Treatment of condyloma acuminatum with three different interferons administered intralesionallv: a double blind placebo controlled trial
. 43:701-702.
1988
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study
. 41:48-50.
1986
Early repair of an external sphincter ani muscle and rectal mucosal dehiscence
. 41:696-697.
1986
Bromocriptine as primary therapy for prolactin secreting macroadenomas; results of a prospective multicenter study
. 40:649-650.
1985
High dose ketoconazole therapy and adrenal and testicular function in humans
. 40:374-375.
1985
Cesarean section: Changing incidence and indications
. 39:437-438.
1984
Microbiologic study of infertile women at the time of diagnostic laparoscopy: Association of ureaplasrna urealyticurn with a defined subpopulation
. 39:110-111.
1984
Retinopathy in toxemia of pregnancy
. 36:485-486.
1981
The natural history of herpes simplex virus infection of mother and newborn
. 36:359-361.
1981
The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns
. 35:735-736.
1980
A role of fetal prolactin in lung maturation
. 33:516-517.
1978
Evaluation of tetracycline or penicillin and ampicillin for treatment of acute pelvic inflammatory disease
. 32:754-756.
1977
The contribution of endocervical smears to cervical cancer detection
. 30:768-769.
1975
Identity
International Standard Serial Number (issn)
0029-7828
1533-9866
Electronic International Standard Serial Number (eissn)
0029-7828
1533-9866